Cumberland Pharmaceuticals, Inc. (CPIX)
3.79
-0.07
(-1.81%)
USD |
NASDAQ |
Feb 03, 16:00
3.82
+0.03
(+0.79%)
After-Hours: 20:00
Cumberland Pharmaceuticals EPS Diluted (Quarterly) : -0.1297 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ImmuCell Corp. | -0.0154 |
| Merck & Co., Inc. | 2.316 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.949M |
| Revenue (Quarterly) | 8.292M |
| Total Expenses (Quarterly) | 10.23M |
| Enterprise Value | 51.41M |
| Gross Profit Margin (Quarterly) | 75.56% |
| Profit Margin (Quarterly) | -23.50% |
| Earnings Yield | -6.15% |
| Normalized Earnings Yield | -5.686 |